Cagrilintide (research designation AM833) is a synthetic 37-amino-acid long-acting amylin analog characterized by lipid-modified backbone substitutions that extend research stability significantly compared to native amylin. With a molecular weight of approximately 4,213.9 Da, it was first described in published metabolic research literature in 2017 and has been studied alongside GL 1P receptor agonists in research models investigating combined amylin and incretin pathway signaling. Also searched as AM833, long-acting amylin, or cagrilintide 10mg, it is supplied as a lyophilized powder for laboratory reference use. Triumphant Labs Cagrilintide is provided strictly for in vitro research applications and is not approved for human or animal use.

DISCLAIMER: By purchasing from Triumphant Labs you agree that you are purchasing Research Chemicals which are in no way intended for use in humans.

Triumphant Labs products are furnished for LABORATORY RESEARCH USE ONLY. This product should only be handled by qualified, and licensed professionals. The product may not be used as a drug, agricultural or pesticidal product, food additive or household chemical – and may not be misbranded as such. Bodily introduction of any kind into humans and/or animals is strictly forbidden by law.

Research Chemicals ARE NOT DIETARY SUPPLEMENTS OR PRESCRIPTION MEDICATIONS THEY ARE *RESEARCH CHEMICALS.

*Research chemicals are chemical substances used by scientists for medical and scientific research purposes. One characteristic of a research chemical is that it is for laboratory research use only; a research chemical is not intended for human or veterinary use. This distinction is required on the labels of research chemicals, and is what exempts them from regulation under parts 100-740 in Title 21 of the Code of Federal Regulations (21CFR).